---
title: "Abridge Finanzierungsrunden-Analyse | AlphaGrowth"
description: "Aktuelle Unternehmensinformationen zu Abridge, Finanzierungsrunden, Gesamtfinanzierung und Mitarbeiterzahl auf AlphaGrowth"
url: "https://alphagrowth.io/de/abridge/company"
---

# Unternehmen Abridge

[Übersicht](https://alphagrowth.io/de/abridge.md) [Wettbewerber](https://alphagrowth.io/de/abridge/competitors.md) [Unternehmen & Investoren](https://alphagrowth.io/de/abridge/company.md)

## Allgemeine Informationen

**Unternehmensname**

Abridge

**Firmenname (rechtlich)**

Abridge AI Inc.

**Adresse**

k. A.

**Land**

United States

**Beschreibung**

Abridge is a medical conversation AI startup that structures and summarize medical conversations for doctors and patients.

**Gesamtfinanzierung**

$752.500.000

**Mitarbeiterzahl**

k. A.

**Externe Links**

[Homepage](https://www.abridge.com) [Facebook](https://www.facebook.com/AbridgeHQ) , [Twitter](https://twitter.com/AbridgeHQ) , [Crunchbase](https://www.crunchbase.com/organization/abridge-d1a4)

## Finanzierungsrunden des Unternehmens

| Runde | Angekündigt am | Anzahl der Investoren | Eingesammelt |
| --- | --- | --- | --- |
| Seed | 2018-11-19 | 2 | |
| Seed | 2019-02-14 | | |
| Pre Seed | 2020-03-26 | 1 | |
| Series A | 2020-10-06 | 8 | $10.000.000 |
| Series A | 2022-08-11 | 7 | $12.500.000 |
| Corporate Round | 2023-05-18 | 1 | |
| Series B | 2023-10-26 | 9 | $30.000.000 |
| Series C | 2024-02-23 | 10 | $150.000.000 |
| Series D | 2025-02-17 | 12 | $250.000.000 |
| Series E | 2025-06-24 | 2 | $300.000.000 |

## Investoren

[American College of Cardiology](https://alphagrowth.io/de/investors/american-college-of-cardiology.md) , [Andreessen Horowitz](https://alphagrowth.io/de/investors/andreessen-horowitz.md) , [ANEESH P. CHOPRA](https://alphagrowth.io/de/investors/aneesh-p-chopra.md) , [Bessemer Venture Partners](https://alphagrowth.io/de/investors/bessemer-venture-partners.md) , [California HealthCare Foundation](https://alphagrowth.io/de/investors/california-healthcare-foundation.md) , [CapitalG](https://alphagrowth.io/de/investors/google-capital.md) , [CVS Health Ventures](https://alphagrowth.io/de/investors/cvs-health-ventures.md) , [Elad Gil](https://alphagrowth.io/de/investors/elad-gil.md) , [Esther Dyson](https://alphagrowth.io/de/investors/esther-dyson.md) , [IKS Health](https://alphagrowth.io/de/investors/iks-health.md) , [IVP](https://alphagrowth.io/de/investors/institutional-venture-partners.md) , [Kaiser Permanente Ventures](https://alphagrowth.io/de/investors/kaiser-permanente-ventures.md) , [KdT Ventures](https://alphagrowth.io/de/investors/kdt-ventures.md) , [Khosla Ventures](https://alphagrowth.io/de/investors/khosla-ventures.md) , [K. Ventures](https://alphagrowth.io/de/investors/k-ventures-650b.md) , [LifePoint Health](https://alphagrowth.io/de/investors/lifepoint-hospitals.md) , [Lightspeed Venture Partners](https://alphagrowth.io/de/investors/lightspeed-venture-partners.md) , [Mass General Brigham](https://alphagrowth.io/de/investors/mass-general-brigham-innovations.md) , [Mayo Clinic](https://alphagrowth.io/de/investors/mayoclinic.md) , [NVentures](https://alphagrowth.io/de/investors/nventures-0731.md) , [Pillar VC](https://alphagrowth.io/de/investors/pillar-companies-2.md) , [Redpoint](https://alphagrowth.io/de/investors/redpoint-ventures.md) , [SCAN Group](https://alphagrowth.io/de/investors/scan-group-1e83.md) , [Spark Capital](https://alphagrowth.io/de/investors/spark-capital.md) , [UCOP](https://alphagrowth.io/de/investors/ucop.md) , [Union Square Ventures](https://alphagrowth.io/de/investors/union-square-ventures.md) , [UPMC](https://alphagrowth.io/de/investors/upmc.md) , [UPMC Enterprises](https://alphagrowth.io/de/investors/upmc-enterprises.md) , [Whistler Capital Partners](https://alphagrowth.io/de/investors/whistler-capital-partners.md) , [Wittington Ventures](https://alphagrowth.io/de/investors/wittington-ventures.md) , [Yoshua Bengio](https://alphagrowth.io/de/investors/yoshua-bengio.md) , [Zen Chu](https://alphagrowth.io/de/investors/zen-chu-2.md)

Insgesamt 32 Investoren

## Mehr TVL für dein Protokoll oder deine Blockchain?

AlphaGrowth steigert den TVL von Protokollen und Blockchains durch Asset-Akquise und -Integration, Grants, Incentives und LP-Deals. Wir haben diese Daten aufgebaut und halten sie kostenlos.

[So steigern wir TVL](https://alphagrowth.io/de/defi/index.md) [Sprich mit AlphaGrowth](https://alphagrowth.io/de/contact-us/index.md)
